aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Marina Temkin
April 22, 2024
Raising young kids who have been diagnosed with, or are suspected of having, ADHD can be challenging. Some children with this condition may have difficulties completing school work or grow easily frustrated and throw tantrums.
Parents who try to turn to professionals for help are often shocked to learn that due to a nationwide shortage of psychologists, it can take as long as nearly a year to get diagnosed and start seeing a therapist. And that’s not even mentioning the high cost of treatment, which can add up to thousands of dollars a year for out-of-network care.
Clarity Pediatrics, a chronic care startup founded in 2021, says it can reduce the wait time for receiving a diagnosis and beginning ADHD therapy from many months to a couple of days, for an average $15 co-pay per session.
The company’s secret sauce is that instead of providing individual therapy to children, the startup runs eight-week group therapy sessions for parents of newly or previously diagnosed kids.
Clarity chose to offer behavioral parent training (BPT) for one simple reason: the American Academy of Pediatrics recommends it for families of children ages five to 12 with mild-to-moderate ADHD. Since young kids are not mature enough to change on their own, BPT teaches parents strategies and skills to help their children focus in school and control emotional outbursts.
“There is no evidence that one-to-one therapy is effective for young kids with ADHD,” said Clarity’s CEO and co-founder Christina LaMontagne.
Over the last 18 months, Clarity has provided online care to thousands of families in California, and it plans to use $10 million in seed funds it raised from Rethink Impact, with participation from Homebrew and Maverick Ventures, to expend its services to other states in 2024.
Clarity is certainly not alone in trying to solve the problem of the lack of therapists for children. Startups like Brightline, Little Otter and Bend Health offer online pediatric mental health services, including ADHD.
For now, Clarity is solely focused on treating ADHD in kids ages five to 12 by providing diagnosis, therapy and prescriptions, but the company has plans to eventually offer healthcare for low-complexity pediatric chronic conditions like asthma, allergies and obesity.
Prior to founding Clarity, LaMontagne was the chief operating officer at Pill Club and a corporate development executive at Johnson & Johnson. The company’s co-founder, Dr. Alesandro Larrazabal, is a pediatrician who was trained at UCSF and Stanford and was in charge of specialty services at Kaiser Permanente.
Clarity’s seed round also included investments from January Ventures, Vamos Ventures, Alumni Ventures and City Light VC.
Heidi Patel, a managing partner at Rethink Impact, said she invested in Clarity because the incidence rate of chronic disease in children has tripled over the last 40 years, but the medical system doesn’t have enough specialists to treat these kids.
“There’s a really long wait time, and then even if you get a diagnosis, treatments are often not available, which is why 80% of kids are left completely untreated,” she said. “With Clarity, you’re getting a full basket of care.”
View original article on techcrunch.com
Share:
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 25, 2024
Eric Schmidt-backed Augment, a GitHub Copilot rival, launches out of stealth with $252M
AI is supercharging coding — and developers are embracing it. In a recent StackOverflow poll, 44% of software engineers said that they use AI tools as part of their development processes now and 26% plan to soon. Gartner estimates that over half of organizations are currently piloting or have already deployed AI-driven coding assistants, and […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Radical thinks the time has come for solar-powered, high-altitude autonomous aircraft
Though many eyes are on space as orbit develops into a thriving business ecosystem, Radical is keeping things a little closer to the ground — but not too close. Its high-altitude, solar-powered aircraft aim to succeed where Facebook’s infamous Aquila failed by refining the tech and embracing more markets. It’s hard to believe that Facebook’s […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Don't miss our latest news and updates. Subscribe to the newsletter
More from Tech Crunch: